PlainRecalls
FDA Drug Critical Class I Terminated

fentaNYL citrate in 0.9% Sodium Chloride Injection, 5 mcg/1 mL (5 mcg/mL), in a) 1 mL syringe (NDC 52533-214-45, UPC: 0100352533214455) and b) 3 mL syringe (NDC 52533-214-60, UPC: 0100352533214608), Rx Only, Cantrell Drug Co., Little Rock, AR

Reported: July 13, 2016 Initiated: August 21, 2015 #D-1156-2016

Product Description

fentaNYL citrate in 0.9% Sodium Chloride Injection, 5 mcg/1 mL (5 mcg/mL), in a) 1 mL syringe (NDC 52533-214-45, UPC: 0100352533214455) and b) 3 mL syringe (NDC 52533-214-60, UPC: 0100352533214608), Rx Only, Cantrell Drug Co., Little Rock, AR

Reason for Recall

Subpotent Drug

Details

Recalling Firm
Cantrell Drug Company
Units Affected
a) 564 syringes and b) 1146 syringes
Distribution
Nationwide
Location
Little Rock, AR

Frequently Asked Questions

What product was recalled?
fentaNYL citrate in 0.9% Sodium Chloride Injection, 5 mcg/1 mL (5 mcg/mL), in a) 1 mL syringe (NDC 52533-214-45, UPC: 0100352533214455) and b) 3 mL syringe (NDC 52533-214-60, UPC: 0100352533214608), Rx Only, Cantrell Drug Co., Little Rock, AR. Recalled by Cantrell Drug Company. Units affected: a) 564 syringes and b) 1146 syringes.
Why was this product recalled?
Subpotent Drug
Which agency issued this recall?
This recall was issued by the FDA Drug on July 13, 2016. Severity: Critical. Recall number: D-1156-2016.